Exploring the Potential of Combining Engineered iPSC NK Cells with NK cell Engagers & the Future of Cell Therapies
Time: 12:00 pm
day: Focus Day - Track B - Afternoon
Details:
- Advantages of IPSC derived NK products vs NK cell line, donor derived, or cord blood
- Advantages of NK cell therapies over CAR-T cell therapies
- Advantages of TALEN over CRISPR
